Hence, targeting SRC has emerged as a promising therapeutic strategy for cancer treatment, and a number of SRC inhibitors have subsequently been developed and tested [4,21,22,23,24,25,26,27,28,29,30]. The gene discussed is SRC; the disease is cancer.